Dexcom to present data and product roadmap at ATTD 2026

Reuters03-11

Dexcom to present data and product roadmap at ATTD 2026

Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event information at https://attd.kenes.com/. Dexcom is scheduled to host a symposium, “Dexcom technology, innovation and clinical implications: Current portfolio, near and long-term vision,” on Thursday, March 12, 2026 from 2:40-4:10 p.m. CET, in Auditorium. Dexcom is scheduled to host a symposium, “Transforming diabetes care: The power of Dexcom CGM from prediabetes to insulin therapy,” on Friday, March 13, 2026 from 8:30-9:20 a.m. CET, in Hall 113, Level P1. Dexcom will present an e-poster, “A reference framework for CGM training and education among healthcare providers,” on March 12, 2026 from 10:10-10:25 a.m. CET and on March 13, 2026 from 10:45-11:00 a.m. CET, at the Dexcom booth, 14A Level P0. Related materials referenced include full release, Dexcom Smart Basal, Dexcom G7 15 Day, and Dexcom Academy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603110200BIZWIRE_USPR_____20260310_BW854672) on March 11, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2618913334?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 14:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618913334","market":"us","top_or_hot":-1,"title":"Dexcom to present data and product roadmap at ATTD 2026","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Dexcom to present data and product roadmap at ATTD 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event information at https://attd.kenes.com/. Dexcom is scheduled to host a symposium, “Dexcom technology, innovation and clinical implications: Current portfolio, near and long-term vision,” on Thursday, March 12, 2026 from 2:40-4:10 p.m. CET, in Auditorium. Dexcom is scheduled to host a symposium, “Transforming diabetes care: The power of Dexcom CGM from prediabetes to insulin therapy,” on Friday, March 13, 2026 from 8:30-9:20 a.m. CET, in Hall 113, Level P1. Dexcom will present an e-poster, “A reference framework for CGM training and education among healthcare providers,” on March 12, 2026 from 10:10-10:25 a.m. CET and on March 13, 2026 from 10:45-11:00 a.m. CET, at the Dexcom booth, 14A Level P0. Related materials referenced include full release, Dexcom Smart Basal, Dexcom G7 15 Day, and Dexcom Academy.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603110200BIZWIRE_USPR_____20260310_BW854672) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dexcom to present data and product roadmap at ATTD 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexcom to present data and product roadmap at ATTD 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-11 14:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Dexcom to present data and product roadmap at ATTD 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event information at https://attd.kenes.com/. Dexcom is scheduled to host a symposium, “Dexcom technology, innovation and clinical implications: Current portfolio, near and long-term vision,” on Thursday, March 12, 2026 from 2:40-4:10 p.m. CET, in Auditorium. Dexcom is scheduled to host a symposium, “Transforming diabetes care: The power of Dexcom CGM from prediabetes to insulin therapy,” on Friday, March 13, 2026 from 8:30-9:20 a.m. CET, in Hall 113, Level P1. Dexcom will present an e-poster, “A reference framework for CGM training and education among healthcare providers,” on March 12, 2026 from 10:10-10:25 a.m. CET and on March 13, 2026 from 10:45-11:00 a.m. CET, at the Dexcom booth, 14A Level P0. Related materials referenced include full release, Dexcom Smart Basal, Dexcom G7 15 Day, and Dexcom Academy.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603110200BIZWIRE_USPR_____20260310_BW854672) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL74xjqQ:1","article_id":"2618913334","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618913334","pubTimestamp":1773208881,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Dexcom to present data and product roadmap at ATTD 2026               Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4548":"巴美列捷福持仓","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","BK4551":"寇图资本持仓","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","DXCM":"德康医疗","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU1923622614.USD":"Natixis Thematics Meta R/A USD","BK4082":"医疗保健设备","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","BK4504":"桥水持仓","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD"},"translate_title":"Dexcom将在ATTD 2026上展示数据和产品路线图","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DXCM":0.9},"content_text":"Dexcom to present data and product roadmap at ATTD 2026\n    \n\n        Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event information at https://attd.kenes.com/. Dexcom is scheduled to host a symposium, “Dexcom technology, innovation and clinical implications: Current portfolio, near and long-term vision,” on Thursday, March 12, 2026 from 2:40-4:10 p.m. CET, in Auditorium. Dexcom is scheduled to host a symposium, “Transforming diabetes care: The power of Dexcom CGM from prediabetes to insulin therapy,” on Friday, March 13, 2026 from 8:30-9:20 a.m. CET, in Hall 113, Level P1. Dexcom will present an e-poster, “A reference framework for CGM training and education among healthcare providers,” on March 12, 2026 from 10:10-10:25 a.m. CET and on March 13, 2026 from 10:45-11:00 a.m. CET, at the Dexcom booth, 14A Level P0. Related materials referenced include full release, Dexcom Smart Basal, Dexcom G7 15 Day, and Dexcom Academy.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603110200BIZWIRE_USPR_____20260310_BW854672) on March 11, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618913334","isCrawlerRequest":true}